Physician profile
Jessica Leonor Cliatt
NPI 1114526753
$1,966.88
in general payments reported to CMS, 2019-2025
15 companies · $672 in 2025
The $672 reported for 2025 was more than what 91% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $666 · 2024: $486 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $414.89 | 2022-2023 | Tivdak |
| Astrazeneca Pharmaceuticals LP | $287.26 | 2022-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $282.60 | 2023-2025 | Lynparza, Keytruda |
| Glaxosmithkline, LLC. | $273.74 | 2023-2025 | Jemperli, Zejula |
| Pfizer INC. | $271.51 | 2025 | |
| Eisai INC. | $95.19 | 2023-2025 | |
| Caris Mpi, INC. | $84.63 | 2025 | Mi Cancer Seek |
| Novartis Pharmaceuticals Corporation | $54.12 | 2024 | |
| Becton, Dickinson and Company | $50.03 | 2024 | Arista Ah Flexitip |
| Coherus Oncology, INC. | $41.10 | 2024-2025 | Udenyca |
| Myriad Genetic Laboratories, INC. | $29.98 | 2024 | Precisetumor |
| Davol INC. | $25.42 | 2024 | Arista Ah Flexitip |
| Immunogen, INC. | $23.93 | 2023 | Elahere |
| Abbvie INC. | $19.78 | 2025 | |
| Hydrofera LLC | $12.70 | 2023 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Cliatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.